Posted on 11월 21, 201911/21/19
Decoding ICER: Successful Pharma Engagement with ICER for U.S. HTA Review
Posted on 11월 8, 201911/8/19
Challenges and Best Practices in Managing Value Based Contracts
Posted on 11월 7, 201911/7/19
Gross-to-Net Improvement Through Holistic Revenue Enhancement
Posted on 11월 1, 201911/1/19
Global Biosimilar Competitor Assessment – Who Wins in Biosimilar Access and Why?
Posted on 10월 28, 201910/28/19
How do we pay for a cure?
Posted on 10월 17, 201910/17/19
Adopting a Patient-Centric Approach to Ensure Safe and Effective Use
Posted on 10월 10, 201910/10/19
Facilitating Positive Patient Outcomes At The Frontline
Posted on 10월 9, 201910/9/19
Navigating Channel Distribution in a New (and more complex) Biopharma World
Posted on 10월 4, 201910/4/19
Patients at the Center of Safe and Effective Therapy
Posted on 10월 4, 201910/4/19